Teva Investors File Suit to Seek Management Pay Details

Teva Pharmaceutical Industries Ltd., which pledged last year to boost transparency under Chief Executive Officer Jeremy Levin, is facing investor pressure in its home country of Israel to reveal individual executive pay.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.